Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Zolopa

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Annals of Internal Medicine|December 28, 1999
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failedA R Zolopa, R W Shafer, A Warford, et al.
AIDS (London, England)|June 21, 2001
Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapyN Shulman, A R Zolopa, D Passaro, et al.
Journal of Clinical Microbiology|April 3, 2001
High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patientsR W Shafer, K Hertogs, A R Zolopa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Genotypic correlates of a virologic response to stavudine after zidovudine monotherapyN S Shulman, R A Machekano, R W Shafer, et al.
AIDS (London, England)|April 19, 2000
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent populationD R Bangsberg, F M Hecht, E D Charlebois, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2000
Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic responseN S Shulman, A R Zolopa, D J Passaro, et al.
The Journal of Infectious Diseases|January 1, 1996
Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patientsY Suzuki, S Y Wong, F C Grumet, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Annals of Internal Medicine|December 28, 1999
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failedA R Zolopa, R W Shafer, A Warford, et al.
AIDS (London, England)|June 21, 2001
Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapyN Shulman, A R Zolopa, D Passaro, et al.
Journal of Clinical Microbiology|April 3, 2001
High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patientsR W Shafer, K Hertogs, A R Zolopa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Genotypic correlates of a virologic response to stavudine after zidovudine monotherapyN S Shulman, R A Machekano, R W Shafer, et al.
AIDS (London, England)|April 19, 2000
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent populationD R Bangsberg, F M Hecht, E D Charlebois, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2000
Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic responseN S Shulman, A R Zolopa, D J Passaro, et al.
The Journal of Infectious Diseases|January 1, 1996
Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patientsY Suzuki, S Y Wong, F C Grumet, et al.
Pageof 2